These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 35142275)
21. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization, Patel MH; Mundada VP; Sawant KK Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488 [No Abstract] [Full Text] [Related]
22. Nanostructured Lipid Carriers to Enhance the Bioavailability and Solubility of Ranolazine: Statistical Optimization and Pharmacological Evaluations. Unnisa A; Chettupalli AK; Alazragi RS; Alelwani W; Bannunah AM; Barnawi J; Amarachinta PR; Jandrajupalli SB; Elamine BA; Mohamed OA; Hussain T Pharmaceuticals (Basel); 2023 Aug; 16(8):. PubMed ID: 37631066 [TBL] [Abstract][Full Text] [Related]
23. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles. Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194 [TBL] [Abstract][Full Text] [Related]
24. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies. Gurumukhi VC; Bari SB Drug Deliv Transl Res; 2022 Jul; 12(7):1753-1773. PubMed ID: 34671949 [TBL] [Abstract][Full Text] [Related]
25. Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Neves AR; LĂșcio M; Martins S; Lima JL; Reis S Int J Nanomedicine; 2013; 8():177-87. PubMed ID: 23326193 [TBL] [Abstract][Full Text] [Related]
26. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
27. Quality by design approach to understand the process of optimization of iloperidone nanostructured lipid carriers for oral bioavailability enhancement. Mandpe L; Pokharkar V Pharm Dev Technol; 2015 May; 20(3):320-9. PubMed ID: 24328553 [TBL] [Abstract][Full Text] [Related]
28. Box-Behnken Design-Based Optimization and Evaluation of Lipid-Based Nano Drug Delivery System for Brain Targeting of Bromocriptine. K M AS; Angolkar M; Rahamathulla M; Thajudeen KY; Ahmed MM; Farhana SA; Shivanandappa TB; Paramshetti S; Osmani RAM; Natarajan J Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931387 [TBL] [Abstract][Full Text] [Related]
29. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Dudhipala N; Veerabrahma K Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287 [TBL] [Abstract][Full Text] [Related]
30. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects. Shi F; Wei Z; Zhao Y; Xu X Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850 [TBL] [Abstract][Full Text] [Related]
31. Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles - Formulation and Pharmacodynamic Assessment. Awadeen RH; Boughdady MF; Meshali MM Int J Nanomedicine; 2020; 15():8553-8568. PubMed ID: 33173292 [TBL] [Abstract][Full Text] [Related]
32. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
33. Optimization of carvedilol solid lipid nanoparticles: An approach to control the release and enhance the oral bioavailability on rabbits. El-Say KM; Hosny KM PLoS One; 2018; 13(8):e0203405. PubMed ID: 30161251 [TBL] [Abstract][Full Text] [Related]
34. Formulation of Lipid-Based Nanocarriers of Lacidipine for Improvement of Oral Delivery: Box-Behnken Design Optimization, Kataria D; Zafar A; Ali J; Khatoon K; Khan S; Imam SS; Yasir M; Ali A Assay Drug Dev Technol; 2022 Jan; 20(1):5-21. PubMed ID: 34978917 [TBL] [Abstract][Full Text] [Related]
35. Nanostructured lipid carriers as a strategy for encapsulation of active plant constituents: Formulation and in vitro physicochemical characterizations. Chaudhari VS; Murty US; Banerjee S Chem Phys Lipids; 2021 Mar; 235():105037. PubMed ID: 33400968 [TBL] [Abstract][Full Text] [Related]
36. QbD-driven development of phospholipid-embedded lipidic nanocarriers of raloxifene: extensive in vitro and in vivo evaluation studies. Pant A; Sharma G; Saini S; Kaur G; Jain A; Thakur A; Singh B Drug Deliv Transl Res; 2024 Mar; 14(3):730-756. PubMed ID: 37768530 [TBL] [Abstract][Full Text] [Related]
37. Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles. Elnaggar YS; El-Massik MA; Abdallah OY Int J Nanomedicine; 2011; 6():3195-205. PubMed ID: 22238508 [TBL] [Abstract][Full Text] [Related]
38. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections. Dudhipala N; Ay AA Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084 [TBL] [Abstract][Full Text] [Related]
39. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity. Aljaeid BM; Hosny KM Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787 [TBL] [Abstract][Full Text] [Related]
40. Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects. Dong Z; Iqbal S; Zhao Z AAPS PharmSciTech; 2020 Jan; 21(2):64. PubMed ID: 31932990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]